METHOD FOR TREATING INTRAOCULAR NEOVASCULAR DISEASES
First Claim
Patent Images
1. A method for treating wet form age-related macular degeneration in a mammal, comprising the steps of:
- a) administering to the mammal a number of first individual doses of an VEGF antagonist; and
b) administering to the mammal a number of second individual doses of the VEGF antagonist,wherein the second individual doses are administered less frequently than the first individual doses.
0 Assignments
0 Petitions
Accused Products
Abstract
A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically effective amount of VEGF antagonist.
-
Citations
21 Claims
-
1. A method for treating wet form age-related macular degeneration in a mammal, comprising the steps of:
-
a) administering to the mammal a number of first individual doses of an VEGF antagonist; and b) administering to the mammal a number of second individual doses of the VEGF antagonist, wherein the second individual doses are administered less frequently than the first individual doses. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21. A method for treating intraocular neovascular disease, comprising:
-
administering to a mammal a number of first individual doses of an VEGF antagonist; followed by, administering to the mammal a number of second individual doses of the antagonist, wherein the second individual doses are administered less frequently than the first individual doses.
-
Specification